PMC Links for Books (Select 4853854) - PMC

Result Filters

Links from Books

Items: 4

Select item 65838421.

Fulminant Hepatitis Associated With Echovirus 25 During Treatment With Ocrelizumab for Multiple Sclerosis

Laura Ambra Nicolini, Paola Canepa, Patrizia Caligiuri, Malgorzata Mikulska, Giovanni Novi, Claudio Viscoli, Antonio Uccelli

JAMA Neurol. 2019 Jul; 76(7): 866–867. Published online 2019 Apr 8. doi: 10.1001/jamaneurol.2019.0522

PMCID:: PMC6583842

Abstract Article

Select item 63439602.

Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis

Maria R Ciardi, Marco Iannetta, Maria A Zingaropoli, Romina Salpini, Marianna Aragri, Rosanna Annecca, Simona Pontecorvo, Marta Altieri, Gianluca Russo, Valentina Svicher, Claudio M Mastroianni, Vincenzo Vullo

Open Forum Infect Dis. 2019 Jan; 6(1): ofy356. Published online 2018 Dec 26. doi: 10.1093/ofid/ofy356

PMCID:: PMC6343960

Abstract Article PDF–202K

Select item 39119473.

Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program

Paul Emery, William Rigby, Paul P. Tak, Thomas Dörner, Ewa Olech, Carmen Martin, Laurie Millar, Helen Travers, Elena Fisheleva

PLoS One. 2014; 9(2): e87379. Published online 2014 Feb 3. doi: 10.1371/journal.pone.0087379

PMCID:: PMC3911947

Abstract Article PDF–898K

Select item 33964594.

Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial

William Stohl, Juan Gomez-Reino, Ewa Olech, Jean Dudler, Roy M Fleischmann, Cristiano A F Zerbini, Ali Ashrafzadeh, Susanna Grzeschik, Rebecca Bieraugel, Jennifer Green, Steven Francom, Wolfgang Dummer

Ann Rheum Dis. 2012 Aug; 71(8): 1289–1296. doi: 10.1136/annrheumdis-2011-200706